<p>Salarius Pharmaceuticals (SLRX) 的股票在周三大幅上涨，此前在周二经历了大幅下跌。周二股票的下跌与其承销的公开发行有关，该发行包括 2,514,335 股股票和预先融资的认股权证，允许购买另外 2,152,331 股。这些股票以每股 1.50 美元的价格出售，导致大约 700 万美元的总收入。</p>
<h3>认识您的 ETF AI 分析师</h3>
<ul>
<li>了解 TipRanks 的 <em>ETF</em> AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong><em>ETF</em> AI 分析师</strong> 对您关注的 ETF 的见解。</li>
</ul>
<p>虽然公开股票发行通常会因发行价格折扣和股东权益稀释而降低公司股票的价值，但股票在发行完成后通常会恢复。投资者会注意到 Salarius Pharmaceuticals 的股票发行定于今天结束，这解释了为什么股票会反弹。</p>
<p>Salarius Pharmaceuticals 还向投资者提供了有关其将如何使用股票发行净收益的详细信息。它打算将这笔资金用于 Salarius 和 Decoy 的临床开发研究与开发项目，偿还 Decoy 的某些未偿还的本票，以及其他一般企业用途。</p>
<h2><strong>Salarius Pharmaceuticals 今日股票走势</strong></h2>
<p>Salarius Pharmaceuticals 的股票在周三上涨了 66.33%，此前周二下跌了 51%。该股票年初至今下跌了 96.45%，过去 12 个月下跌了 95.37%。</p>
<p>随着今日消息的发布，SLRX 股票交易活跃，超过 2700 万股易手，而三个月的日均交易量约为 356,000 股。该股票在周二也经历了大量交易，约有 587 万股被交换。</p>

SLRX

<p>Salarius Pharmaceuticals (SLRX) 的股票在周三上涨了 66.33%，此前由于进行了一项超过 250 万股、每股 1.50 美元的承销公开发行，导致股价大幅下跌，筹集了大约 700 万美元。股票通常在发行后会反弹，而此次发行预计今天结束。筹集的资金将用于临床开发并偿还 Decoy 的本票。尽管股价反弹，SLRX 年初至今仍下跌了 96.45%，过去一年下跌了 95.37%，今天的交易量超过 2700 万股</p>

<p>Salarius Pharmaceuticals (SLRX) stock rocketed higher on Wednesday following a massive fall yesterday. The drop the stock experienced on Tuesday was related to its underwritten public offering, which included 2,514,335 shares and pre-funded warrants to purchase another 2,152,331 shares. These were sold for $1.50 per share, resulting in gross proceeds of approximately $7 million.</p>
<div class="lb-trans"><p>Salarius Pharmaceuticals (SLRX) 的股票在周三大幅上涨，此前在周二经历了大幅下跌。周二股票的下跌与其承销的公开发行有关，该发行包括 2,514,335 股股票和预先融资的认股权证，允许购买另外 2,152,331 股。这些股票以每股 1.50 美元的价格出售，导致大约 700 万美元的总收入。</p>
</div><h3>Meet Your ETF AI Analyst</h3>
<div class="lb-trans"><h3>认识您的 ETF AI 分析师</h3>
</div><ul>
<li>Discover how TipRanks' <em>ETF</em> AI Analyst can help you make smarter investment decisions</li>
<li>Explore ETFs TipRanks' users love and see what insights the <strong><em>ETF</em> AI Analyst</strong> reveals about the ones you follow.</li>
</ul>
<div class="lb-trans"><ul>
<li>了解 TipRanks 的 <em>ETF</em> AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong><em>ETF</em> AI 分析师</strong> 对您关注的 ETF 的见解。</li>
</ul>
</div><p>While it's common for a public stock offering to reduce the value of a company's shares, due to the side effect of a discounted price in the offering and the dilution of shareholder stakes, the stock often recovers when the offering is complete. Investors will note that the Salarius Pharmaceuticals stock offering was set to close today, which explains why the stock has rallied.</p>
<div class="lb-trans"><p>虽然公开股票发行通常会因发行价格折扣和股东权益稀释而降低公司股票的价值，但股票在发行完成后通常会恢复。投资者会注意到 Salarius Pharmaceuticals 的股票发行定于今天结束，这解释了为什么股票会反弹。</p>
</div><p>Salarius Pharmaceuticals also provided investors with details about what it would do with the net proceeds from the stock offering. It intends to spend the money on clinical development of Salarius' and Decoy's research and development programs, pay off certain of Decoy's outstanding promissory notes, and other general corporate purposes.</p>
<div class="lb-trans"><p>Salarius Pharmaceuticals 还向投资者提供了有关其将如何使用股票发行净收益的详细信息。它打算将这笔资金用于 Salarius 和 Decoy 的临床开发研究与开发项目，偿还 Decoy 的某些未偿还的本票，以及其他一般企业用途。</p>
</div><h2><strong>Salarius Pharmaceuticals Stock Movement Today</strong></h2>
<div class="lb-trans"><h2><strong>Salarius Pharmaceuticals 今日股票走势</strong></h2>
</div><p>Salarius Pharmaceuticals stock was up 66.33% on Wednesday, following a 51% fall yesterday. The stock has decreased 96.45% year-to-date and 95.37% over the past 12 months.</p>
<div class="lb-trans"><p>Salarius Pharmaceuticals 的股票在周三上涨了 66.33%，此前周二下跌了 51%。该股票年初至今下跌了 96.45%，过去 12 个月下跌了 95.37%。</p>
</div><p>With today's news came heavy trading of SLRX stock, as more than 27 million shares changed hands, compared to a three-month daily average of about 356,000 units. The stock also saw heavy trading yesterday, when roughly 5.87 million shares were exchanged.</p>
<div class="lb-trans"><p>随着今日消息的发布，SLRX 股票交易活跃，超过 2700 万股易手，而三个月的日均交易量约为 356,000 股。该股票在周二也经历了大量交易，约有 587 万股被交换。</p>
</div>

为什么 Salarius Pharmaceuticals 的股票（SLRX）今天上涨了 65%？